Navigation Links
Stem cells derived from human amniotic fluid hold promise
Date:8/24/2011

F O R I M M E D I A T E R E L E A S E

CELL TRANSPLANTATION The Regenerative Medicine Journal

Stem cells derived from human amniotic fluid hold promise hAECs used to successfully treat animal models of lung disease

Tampa, Fla. (Aug. 24, 2011) Two papers published in the current issue of Cell Transplantation (20:6), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

Amniotic fluid a rich source of mesenchymal stromal cells "Stem cells isolated from human amniotic fluid (AFSs) have the ability to differentiate into different cell types," said study corresponding author Dr. Cesar V. Borlongan, professor and vice chair for research in the University of South Florida's Department of Neurosurgery and Brain Repair. "Recent research has shown that amniotic fluid-derived stem cells show similarities to both embryonic and adult stem cells and can differentiate into many different kinds of cells." The study authors determined that amniotic fluid-derived stem cells represent not only a promising source of stem cells for further research, but may also serve as a "customized cell supply" for the newly born. The cells have the capacity to be "banked" for transplantation in immunologically-matched recipients. According to the authors, AFSs can give rise to adipogenic, osteogenic, myogenic, neurogenic and hepatic cell lineages. The cells, they said, are "intermediate between embryonic stem cells and adult stem cells." "These cells have a high renewal capacity and can be expanded without loss of cellular integrity, such as a loss of chromosomal telomere length," explained Dr. Borlongan. "We need further investigations to fully explore the amniotic cells' potential for treating adult human disorders." Contact: Dr. Cesar V. Borlongan, professor and vice chair for research, Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL 33612 Tel. (813) 974-3154 Fax. (813) 974-3078 Email cborlong@health.usf.edu

Citation: Antonucci, I.; Stuppia, L.; Kaneko, Y.; Yu, S.; Tajiri, N.; Bae, E. C.; Chheda, S. H.; Weinbren, N. L.; Borlongan, C. V. Amniotic Fluid as Rich Source of Mesenchymal Stromal Cells for Transplantation Therapy. Cell Transplant. 20(6):789-795; 2011.

Tampa, Fla. (Aug. 24, 2011) Two papers published in the current issue of Cell Transplantation (20:6), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

Amniotic fluid a rich source of mesenchymal stromal cells

"Stem cells isolated from human amniotic fluid (AFSs) have the ability to differentiate into different cell types," said study corresponding author Dr. Cesar V. Borlongan, professor and vice chair for research in the University of South Florida's Department of Neurosurgery and Brain Repair. "Recent research has shown that amniotic fluid-derived stem cells show similarities to both embryonic and adult stem cells and can differentiate into many different kinds of cells."

The study authors determined that amniotic fluid-derived stem cells represent not only a promising source of stem cells for further research, but may also serve as a "customized cell supply" for the newly born. The cells have the capacity to be "banked" for transplantation in immunologically-matched recipients.

According to the authors, AFSs can give rise to adipogenic, osteogenic, myogenic, neurogenic and hepatic cell lineages. The cells, they said, are "intermediate between embryonic stem cells and adult stem cells."

"These cells have a high renewal capacity and can be expanded without loss of cellular integrity, such as a loss of chromosomal telomere length," explained Dr. Borlongan. "We need further investigations to fully explore the amniotic cells' potential for treating adult human disorders."


'/>"/>

Contact: David Eve
celltransplantation@gmail.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. NSF funds new Center for the Physics of Living Cells at Illinois
3. When cells go bad
4. The role of stem cells in renewing the cornea
5. Breast cancer cells recycle to escape death by hormonal therapy
6. Models of eel cells suggest electrifying possibilities
7. Scientists identify a molecule that coordinates the movement of cells
8. Form of Crohns disease traced to disabled gut cells
9. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
10. Researchers design artificial cells that could power medical implants
11. Stabilizing force for good communication between neurons and muscle cells found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... 2016 Technology Enhancements Accelerate Growth of X-ray Imaging ... digital and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth ... well as regional market drivers and restraints. The study ... and market attractiveness, both for digital and computed radiography. ...
(Date:2/1/2016)... , February 1, 2016 Rising ... to drive global touchfree intuitive gesture control market ... Rising sales of consumer electronics coupled with new ... market size through 2020   ... coupled with new technological advancements to drive global touchfree ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 4, 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today provided an update on ... Northern District of Texas and ... Inter Partes Re-examination ("IPR") proceedings that VTech ... IPR was initiated on only certain claims of two ...
(Date:2/4/2016)... 4, 2016 Strasbourg, France ... --> Strasbourg, France , to the ... PharmaVentures is pleased to announce that it acted as an ... unit in Strasbourg, France , to the ... --> --> Transgene (Euronext: TNG), a member ...
(Date:2/3/2016)... Pa. , Feb. 3, 2016  Discovery ... company focused on developing aerosolized KL4 surfactant therapies ... of Directors has approved an inducement award as ... Fraser , its newly appointed President and Chief ... Board,s Compensation Committee on February 1, 2016 and ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 Harvard ... a biotechnology company developing bioengineered organ implants for ... today announced that CEO Jim McGorry , ... Investor Conference on Tuesday, February 9, 2016 ... York City . HART,s presentation will be ...
Breaking Biology Technology: